FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
Clinical trial NCT06260670 · COMPLETED
Trial details
- NCT number
- NCT06260670
- Sponsor
- Ablacon, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2022-10-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.